Literature DB >> 11231010

Enzymatic synthesis of a novel trehalose derivative, 3,3'-diketotrehalose, and its potential application as the trehalase enzyme inhibitor.

K Sode1, E Akaike, H Sugiura, W Tsugawa.   

Abstract

We reported the preparation of a novel trehalose derivative based on enzymatic oxidation of trehalose by water-soluble glucose-3-dehydrogenase (G3DH) from marine bacterium Halomonas sp. alpha-15 cells. The product of G3DH enzymatic conversion was 3,3'-diketotrehalose (3,3'dkT), a novel trehalose derivative of which both third hydroxy groups of glucopyranosides were oxidized. 3,3'dkT was revealed to show an inhibitory effect toward pig-kidney and Bombyx mori trehalases. The IC(50) values of 3,3'dkT were 0.8 and 2.5 mM and K(i) values were 0.2 and 0.6 mM for pig-kidney and for B. mori trehalases, respectively. In addition, 3,3'dkT did not show any inhibitory effect on both maltase and mannosidase activities. Therefore, 3,3'dkT was a specific inhibitor of trehalases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231010     DOI: 10.1016/s0014-5793(00)02427-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Gene cloning and expression of a glucoside 3-dehydrogenase from Sphingobacterium faecium ZJF-D6, and used it to produce N-p-nitrophenyl-3-ketovalidamine.

Authors:  Jian-Fen Zhang; Wei-Qing Chen; Hong Chen
Journal:  World J Microbiol Biotechnol       Date:  2017-01-02       Impact factor: 3.312

2.  TPS1 drug design for rice blast disease in magnaporthe oryzae.

Authors:  Yangkui Xue; Guanghou Shui; Markus R Wenk
Journal:  Springerplus       Date:  2014-01-10

3.  RNA-seq of muscle from pigs divergent in feed efficiency and product quality identifies differences in immune response, growth, and macronutrient and connective tissue metabolism.

Authors:  Justyna Horodyska; Klaus Wimmers; Henry Reyer; Nares Trakooljul; Anne Maria Mullen; Peadar G Lawlor; Ruth M Hamill
Journal:  BMC Genomics       Date:  2018-11-01       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.